Cargando…
A pilot randomized controlled trial of pioglitazone for the treatment of poorly controlled asthma in obesity
BACKGROUND: Obese asthmatics tend to have poorly controlled asthma, and resistance to standard asthma controller medications. The purpose of this study was to determine the efficacy of pioglitazone, an anti-diabetic medication which can alter circulating adipokines and have direct effects on asthmat...
Autores principales: | Dixon, Anne E., Subramanian, Meenakumari, DeSarno, Michael, Black, Kendall, Lane, Lisa, Holguin, Fernando |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4661996/ https://www.ncbi.nlm.nih.gov/pubmed/26610598 http://dx.doi.org/10.1186/s12931-015-0303-6 |
Ejemplares similares
-
The challenge of addressing obesity in people with poorly controlled asthma
por: Dixon, Anne E., et al.
Publicado: (2021) -
Arginine and Nitric Oxide Pathways in Obesity-Associated Asthma
por: Holguin, Fernando
Publicado: (2013) -
Evaluation of the PPAR-γ Agonist Pioglitazone in Mild Asthma: A Double-Blind Randomized Controlled Trial
por: Anderson, J. R., et al.
Publicado: (2016) -
Asthma and obesity: mechanisms and clinical implications
por: Baffi, Cynthia Wilson, et al.
Publicado: (2015) -
The impact of bariatric surgery on asthma control differs among obese individuals with reported prior or current asthma, with or without metabolic syndrome
por: Forno, Erick, et al.
Publicado: (2019)